Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for NGM Biopharmaceuticals, Inc.
Goto 0, 1, 2, ...6, 7, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-01-30
Purchase
2023-02-01
4:50 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-30
Purchase
2023-02-01
4:31 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-30
Purchase
2023-02-01
4:29 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-30
Purchase
2023-02-01
4:26 pm
NGM BIOPHARMACEUTICALS INCNGMGOEDDEL DAVID V
Director
10% Owner
184,272$4.9986$921,11021,981,782
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:38 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:35 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:31 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:26 pm
NGM BIOPHARMACEUTICALS INCNGMGOEDDEL DAVID V
Director
10% Owner
9,900$4.9994$49,49421,797,510
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:25 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:22 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:19 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:16 pm
NGM BIOPHARMACEUTICALS INCNGMGOEDDEL DAVID V
Director
10% Owner
38,139$4.9976$190,60321,787,610
(Indirect
Direct)
View
2023-01-17
Sale
2023-01-18
4:06 pm
NGM BIOPHARMACEUTICALS INCNGMCHEN JIN-LONG
Chief Scientific Officer
85,082$5.1516$438,308908,893
(Direct)
View
2023-01-12
Purchase
2023-01-17
4:36 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-12
Purchase
2023-01-17
4:34 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-12
Purchase
2023-01-17
4:32 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-12
Purchase
2023-01-17
4:31 pm
NGM BIOPHARMACEUTICALS INCNGMGOEDDEL DAVID V
Director
10% Owner
5,378$4.9466$26,60321,749,471
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:40 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:37 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:35 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:32 pm
NGM BIOPHARMACEUTICALS INCNGMGOEDDEL DAVID V
Director
10% Owner
309,070$4.7865$1,479,35921,744,093
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:31 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:29 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:28 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:24 pm
NGM BIOPHARMACEUTICALS INCNGMGOEDDEL DAVID V
Director
10% Owner
300$4.9767$1,49321,435,023
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:21 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:17 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:14 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:11 pm
NGM BIOPHARMACEUTICALS INCNGMGOEDDEL DAVID V
Director
10% Owner
40,327$4.9988$201,58821,434,723
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-10
Option Award
2023-05-12
5:54 pm
N/A
2033-05-09
NGM BIOPHARMACEUTICALS INCNGMGuyer Shelly D
Director
78,407$078,407
(Direct)
View
2023-05-10
Option Award
2023-05-12
5:52 pm
N/A
2033-05-09
NGM BIOPHARMACEUTICALS INCNGMRIEFLIN WILLIAM JL
Director
78,407$078,407
(Direct)
View
2023-05-10
Option Award
2023-05-12
5:51 pm
N/A
2033-05-09
NGM BIOPHARMACEUTICALS INCNGMHooper Suzanne Sawochka
Director
78,407$078,407
(Direct)
View
2023-05-10
Option Award
2023-05-12
5:50 pm
N/A
2033-05-09
NGM BIOPHARMACEUTICALS INCNGMGOEDDEL DAVID V
Director
10% Owner
78,407$078,407
(Direct)
View
2023-05-10
Option Award
2023-05-12
5:49 pm
N/A
2033-05-09
NGM BIOPHARMACEUTICALS INCNGMPERLMUTTER ROGER M
Director
78,407$078,407
(Direct)
View
2023-05-10
Option Award
2023-05-12
5:48 pm
N/A
2033-05-09
NGM BIOPHARMACEUTICALS INCNGMHo Carole
Director
78,407$078,407
(Direct)
View
2023-03-02
Option Award
2023-03-06
5:12 pm
N/A
2033-03-01
NGM BIOPHARMACEUTICALS INCNGMNolan Mangini Siobhan
President and CFO
504,000$0504,000
(Direct)
View
2023-03-02
Option Award
2023-03-06
5:09 pm
N/A
2033-03-01
NGM BIOPHARMACEUTICALS INCNGMWOODHOUSE DAVID J
Chief Executive Officer
1,008,800$01,106,454
(Direct)
View
2023-03-02
Option Award
2023-03-06
5:08 pm
N/A
2033-03-01
NGM BIOPHARMACEUTICALS INCNGMLieu Hsiao D
SVP, Chief Medical Officer
212,000$0214,605
(Direct)
View
2023-03-02
Option Award
2023-03-06
5:05 pm
N/A
2033-03-01
NGM BIOPHARMACEUTICALS INCNGMCHEN JIN-LONG
Chief Scientific Officer
431,000$01,339,893
(Direct)
View
2023-03-02
Option Award
2023-03-06
5:03 pm
N/A
2033-03-01
NGM BIOPHARMACEUTICALS INCNGMPierce Valerie L
SVP, GC & CCO
346,000$0352,667
(Direct)
View
2023-01-17
Exercise
2023-01-18
4:06 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCHEN JIN-LONG
Chief Scientific Officer
85,082$1.44908,893
(Direct)
View
2023-01-17
Exercise
2023-01-18
4:06 pm
N/A
2023-01-23
NGM BIOPHARMACEUTICALS INCNGMCHEN JIN-LONG
Chief Scientific Officer
85,082$0908,893
(Direct)
View
Goto 0, 1, 2, ...6, 7, Next